Joachim Ix, MD
Nephrology · San Diego, CANPI 1720017536
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,586 of the $25,125 with a category attached, or 85.9%. 8 manufacturers reported payments, led by Bayer at 52.3% of the total. Reporting peaked in 2022 at $14,500 and has fallen 90.5% since, to $1,372 in 2025. Among nephrology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $738.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$13K
- AstraZeneca$7K
- Akebia Therapeutics Inc$2K
- Immedica Pharma US, Inc.$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$730
- Astrazeneca UK Limited$490
- plus $155 from 2 others
Across 7 payments — averaging $6656.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Baxter Healthcare$36K
- Boehringer Ingelheim International GmbH$11K
What the payments were for
- Consulting fees$21,58686%
- Travel & lodging$2,2329%
- Food & beverage$1,3025%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 18 | $13,152 |
| AstraZeneca | 6 | $6,528 |
| Akebia Therapeutics Inc | 2 | $2,495 |
| Immedica Pharma US, Inc. | 2 | $1,575 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $730 |
| Astrazeneca UK Limited | 1 | $490 |
| Philips North America LLC | 1 | $150 |
| Travere Therapeutics, Inc. | 3 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$11,971
- LOKELMA$5,446
- Non-Covered$1,013
- FARXIGA$490
- ZTALMY$450
- (3126) ECC Solutions$150
- AURYXIA$135
How this compares
$25,125 in reported general payments places this provider in the 90th percentile of 1,341 nephrology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in San Diego
- Ravindra MehtaSan Diego$184K
- Ambarish AthavaleSan Diego$83K
- Juan QuevedoSan Diego$53K
- Anjay RastogiLos Angeles$2.2M
- Glenn ChertowStanford$2M
- Luis AlvarezPalo Alto$1.8M
- Jose MorfinSacramento$1M
- Rodolfo BatarseRancho Mirage$910K
- Vandana MathurWoodside$769K
- Yasir QaziOrange$618K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.